Search
for
Sort by
Research 511–540 of 587
- Vitiligo—Current Treatment Options and Future Perspectives
- Alopecia areata: current concepts
- The Protective and Regenerative Potential of Lactoferrin in Hair and Skin Health
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Stem cell-based therapies for alopecia areata: a narrative review
- Efficacy of Intralesional Triamcinolone Acetonide Combined With Cryotherapy Compared to Intralesional Triamcinolone Acetonide Alone in Treating Limited Patchy Alopecia Areata of the Scalp and Face: A Prospective, Randomized, Within‐Subject Controlled Trial
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Th,-e mechanistic insights into the application of retinoids and possible adjunct therapeutic treatment to androgenic alopecia
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- The Involvement of RIPK1 in Alopecia Areata
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities